Sort   by:  
 Page size 
UnknownA randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naive patients with metastatic melanoma.
Not available
S-EPMC6279094 | biostudies-literature
UnknownOverall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma.
Not available
S-EPMC7279645 | biostudies-literature
UnknownAdjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915).
Not available
S-EPMC9870220 | biostudies-literature
Sort   by:  
 Page size